Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control RateSAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a ...
Learn what a basic extended reporting period (BERP) is, how it aids policyholders with claims-made policies, and the difference between BERP and supplemental coverage.
The Company will host an investor conference call at 10:00 a.m. Eastern Time on Friday, February 6, 2026 to discuss its ...
Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results